Psych News Alert | FDA (4)

FDA Narrows Use of New Alzheimer’s Drug to Early Stage Patients

7/9/21 12:00 AM

Lybalvi Approved for Schizophrenia, Bipolar I Disorder in Adults

6/11/21 12:00 AM

Alzheimer’s Antibody Therapy Receives Accelerated Approval Amid Controversy

6/8/21 12:00 AM

FDA Authorizes Marketing of New Aid to Diagnose Autism

6/3/21 12:00 AM

FDA Approves Once-Daily Nonstimulant for Treatment of ADHD

4/8/21 12:00 AM

FDA OKs App That Disrupts Nightmares Associated With PTSD

11/12/20 12:00 AM

Prescribing of Antipsychotics to Young Children Is Declining, Study Suggests

10/27/20 12:00 AM

FDA Loosens Restrictions on REMS for Medications, CMS Grants Exceptions on Quality Reporting

3/24/20 12:00 AM

In response to the unfolding COVID-19 public health crisis, federal agencies have announced new chan...

FDA Warns Untreated Constipation From Clozapine Use Can Lead to Serious Bowel Complications

1/30/20 12:00 AM

The FDA on Tuesday issued an updated warning that constipation caused by the antipsychotic clozapine...